StockNow
Calendar
Log in
Global Markets

ASML (ASML NA) CFO says demand for Terafab is included in the forecasts in 2027 and beyond; if the US Match Act limits sales of DUVs to China, it will prove counterproductive; Impact of price increases will be visible, starting 2027

StockNow breaking-news AI analysis

ASML’s CFO said Terafab demand is in forecasts from 2027 onward, potential Match Act limits on DUV sales to China would be counterproductive, and price-increase effects begin showing in 2027.

1 stocks
ASMLASML Holding NV$1,707.30Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
Global Markets

ASML (ASML NA) Q3 2026 (EUR): Basic EPS 12.95 (exp. 10.68), Revenue 11.66bln (exp. 11.58bln)

ASMLGeopolitics

SNN reports that "severe explosions shake Jeddah, Saudi Arabia"; some reports suggest strikes have targeted the Aramco oil refinery in Jeddah

Geopolitics

IRGC Navy says that a container ship carrying 2,500 containers sank south of the Strait of Hormuz, Sepah News reports